SPECT and PET imaging of EGF receptors with site-specifically labeled EGF and dimeric EGF

Bioconjug Chem. 2009 Apr;20(4):742-9. doi: 10.1021/bc800443w.

Abstract

We describe a new generation of tracers for molecular imaging of the cell surface receptors for epidermal growth factor (EGF). These receptors play a key role in the progression of many tumors and are major drug development targets. Our tracers are based on a recombinant human EGF expressed with a cysteine-containing tag that enables facile site-specific radiolabeling with (99m)Tc for single photon emission computed tomography or site-specific conjugation of (64)Cu PEGylated chelators for positron emission tomography. These tracers retain EGF activities in vitro and display selective and highly specific focal uptake in tumors in vivo. We expect that nuclear imaging of EGF receptors with these tracers will be useful for clinical diagnosis, therapeutic monitoring, and development of new drugs and treatment regimens.

MeSH terms

  • Animals
  • Autoradiography
  • Binding Sites
  • Cell Line, Tumor
  • Chelating Agents / chemistry
  • Cystine / chemistry
  • Epidermal Growth Factor / chemistry
  • Epidermal Growth Factor / metabolism*
  • Epidermal Growth Factor / pharmacokinetics
  • ErbB Receptors / analysis*
  • ErbB Receptors / metabolism
  • Heterocyclic Compounds, 1-Ring / chemistry
  • Humans
  • Male
  • Mice
  • Organotechnetium Compounds / chemistry
  • Polyethylene Glycols / chemistry
  • Positron-Emission Tomography
  • Protein Multimerization*
  • Protein Structure, Quaternary*
  • Rats
  • Staining and Labeling
  • Substrate Specificity
  • Tissue Distribution
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Chelating Agents
  • Heterocyclic Compounds, 1-Ring
  • Organotechnetium Compounds
  • 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
  • Polyethylene Glycols
  • Cystine
  • Epidermal Growth Factor
  • ErbB Receptors